These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 9817745)

  • 1. Leukotrienes as mediators of airway obstruction.
    Drazen JM
    Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 3):S193-200. PubMed ID: 9817745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle.
    Jonsson EW
    Acta Physiol Scand Suppl; 1998 Mar; 641():1-55. PubMed ID: 9597121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part I: synthesis, receptors and role of leukotrienes in asthma.
    Devillier P; Baccard N; Advenier C
    Pharmacol Res; 1999 Jul; 40(1):3-13. PubMed ID: 10378985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
    Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T
    Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-gamma modulates cysteinyl leukotriene receptor-1 expression and function in human airway myocytes.
    Amrani Y; Moore PE; Hoffman R; Shore SA; Panettieri RA
    Am J Respir Crit Care Med; 2001 Dec; 164(11):2098-101. PubMed ID: 11739141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CysLT2 receptors in asthma lung, and their possible role in bronchoconstriction.
    Sekioka T; Kadode M; Fujii M; Kawabata K; Abe T; Horiba M; Kohno S; Nabe T
    Allergol Int; 2015 Oct; 64(4):351-8. PubMed ID: 26433531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of receptors and modulatory mechanisms in functional responses to cysteinyl-leukotrienes in smooth muscle.
    Bäck M
    Acta Physiol Scand Suppl; 2002 Feb; 648():1-55. PubMed ID: 11913222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cysteinyl-leukotrienes induce vascular endothelial growth factor production in human monocytes and bronchial smooth muscle cells.
    Poulin S; Thompson C; Thivierge M; Véronneau S; McMahon S; Dubois CM; Stankova J; Rola-Pleszczynski M
    Clin Exp Allergy; 2011 Feb; 41(2):204-17. PubMed ID: 21121979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Airway smooth muscle as a target of glucocorticoid action in the treatment of asthma.
    Hirst SJ; Lee TH
    Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 3):S201-6. PubMed ID: 9817746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophils and cysteinyl leukotrienes.
    Bandeira-Melo C; Weller PF
    Prostaglandins Leukot Essent Fatty Acids; 2003; 69(2-3):135-43. PubMed ID: 12895596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukotriene receptors are differently expressed in fibroblast from peripheral versus central airways in asthmatics and healthy controls.
    Tufvesson E; Nihlberg K; Westergren-Thorsson G; Bjermer L
    Prostaglandins Leukot Essent Fatty Acids; 2011 Aug; 85(2):67-73. PubMed ID: 21596548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling.
    Holgate ST; Peters-Golden M; Panettieri RA; Henderson WR
    J Allergy Clin Immunol; 2003 Jan; 111(1 Suppl):S18-34; discussion S34-6. PubMed ID: 12532084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Status of leukotrienes in the pathophysiology of asthma. Necessity for antileukotrienes treatment].
    Fal AM; Kopeć A
    Pneumonol Alergol Pol; 2010; 78(1):68-73. PubMed ID: 20162521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of cysteinyl leukotrienes in airway smooth muscle cell DNA synthesis after repeated allergen exposure in sensitized Brown Norway rats.
    Salmon M; Walsh DA; Huang TJ; Barnes PJ; Leonard TB; Hay DW; Chung KF
    Br J Pharmacol; 1999 Jul; 127(5):1151-8. PubMed ID: 10455261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cysteinyl leukotrienes and their receptors: molecular and functional characteristics.
    Singh RK; Gupta S; Dastidar S; Ray A
    Pharmacology; 2010; 85(6):336-49. PubMed ID: 20516735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cysteinyl-leukotrienes in the regulation of beta2-adrenoceptor function: an in vitro model of asthma.
    Rovati GE; Baroffio M; Citro S; Brichetto L; Ravasi S; Milanese M; Crimi E; Brusasco V
    Respir Res; 2006 Jul; 7(1):103. PubMed ID: 16875498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cysteinyl leukotrienes: where do they come from? What are they? Where are they going?
    Austen KF
    Nat Immunol; 2008 Feb; 9(2):113-5. PubMed ID: 18204420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient receptor potential vanilloid 4 activation constricts the human bronchus via the release of cysteinyl leukotrienes.
    McAlexander MA; Luttmann MA; Hunsberger GE; Undem BJ
    J Pharmacol Exp Ther; 2014 Apr; 349(1):118-25. PubMed ID: 24504097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bitter taste receptors on airway smooth muscle bronchodilate by localized calcium signaling and reverse obstruction.
    Deshpande DA; Wang WC; McIlmoyle EL; Robinett KS; Schillinger RM; An SS; Sham JS; Liggett SB
    Nat Med; 2010 Nov; 16(11):1299-304. PubMed ID: 20972434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extending the understanding of leukotrienes in asthma.
    Coffey M; Peters-Golden M
    Curr Opin Allergy Clin Immunol; 2003 Feb; 3(1):57-63. PubMed ID: 12582316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.